Fostamatinib, a spleen tyrosine kinase inhibitor, exerts excellent anti-inflammatory activity via inhibiting STAT1/3 signaling pathways
Published: 26 June 2024| Version 1 | DOI: 10.17632/x6nnxygn48.1
Contributor:
Ran GuoDescription
Transcriptome sequencing data of fostamatinib
Files
Categories
Medicine